Company Directory / biotechnology
PrivateFor profitbiotechnologyAbingdon, United Kingdom
Oxagen
Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.
- Founded
- 1997 29 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $131M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
29 years old.
Reach
No web traffic ranking listed.
What it does
BiopharmaBiotechnologyHealth CarePharmaceutical
Funding, as listed
$131M currency not stated
- Rounds3
- LatestSeries c, Nov 2009
- Investors19, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Oxagen, field by field. Contact details are held but never shown.
The company
- Name
- Oxagen
- Type
- For profit
- Status
- Private
- Founded
- 1997
- Industry
- biotechnology
- Categories
- Biopharma, Biotechnology, Health Care, Pharmaceutical
Where
- City
- Abingdon
- Country
- United Kingdom
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 11-50
Funding, as listed
- Total
- 130,740,218 (currency not stated)
- Rounds
- 3
- Latest round
- Series c
- Latest round date
- Nov 2009
- Investors
- 19
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
biotechnology in United Kingdom.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.